One drop of blood is all it takes
to test for any biomarker at home

DEMOCRATIZING

CLINICAL DATA

Investors SARS-CoV-2

INVESTORS

About

The company has a product for blood biomarker testing. Customers demand this type of product and several contacts have already been made with vital institutions in Denmark. Sales for professional use are commenced in 2020.

Read more

Investors

Here you will find the share information for Qlife Holding AB. Our press releases and financial quarterly reports, our annual reports, calendar and information about our corporate governance work. Qlife Holding AB aims for a fast and transparent accounting to shareholders and the financial market.

The company is listed on Nasdaq, First North Growth Market, Stockholm as from March 2, 2020

Continue

Egoo.health

The Egoo product is a platform for accurate bio-marker testing. At a low cost and with equipment easy to use, it measures and analyses the patient’s blood. The patient can do the testing at home themselves. Read more on our product page.

Egoo.health

Contact

If you have any questions about us or our ongoing IPO feel free to send us a message.

 

 

You agree by using this feature that your information is handled in accordance with applicable GDPR legislation.
2 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Film - EGOO HEALTH EXPLAINED

In less than four minutes, CEO Thomas Warthoe explains what Egoo Health is all about, how it works and why it makes a difference for ordinary people, medical staff and health institutions. 

Read more about us

NEWS/PRESS

2020-07-08
Qlife hires Jakob Broberg Lind as Sales Director Clinical

Jakob has extensive experience from international sales and business development within MedTech and healthcare and brings an excellent record of results and achievements in complex and competitive

2020-07-06
News letter - commercial activities and communication

In April we closed a contract with the professional Danish football league for regular testing of all players and staff for COVID-19 and delivery of test results were initiated already in week 22.

2020-06-22
Henrik Ljung will take the role of Chief Financial Officer, CFO, in Qlife Holding AB.

"Henrik Ljung brings broad experience to Qlife from financial reporting, IR, business control, finance management and corporate governance, all with a focus on fast-growing companies in the ea

2020-06-19
Qlife tests badminton players for COVID-19, for this weekend's RSL Final 4 play

KMD and Qlife has entered an agreement with Badmint

2020-06-04
MOVING CLOSER TO THE MARKET - PROFESSIONAL SPORTS, CULTURE AND ENTERTAINMENT

Geelmuyden Kiese and KMD announced earlier today that they have entered a partnership to provide smart and efficient Covid-19 test solutions for the professional sports, culture, and entertainment

2020-06-02
Qlife to develop SARS-CoV-2 total antibody test

The first phase of developing the antibody test will be outsourced to an existing partner and is expected to take approximately three months.

2020-05-20
Bulletin from the Annual General Meeting in Qlife Holding AB on May 20th, 2020

Resolution on adoption of accounts and allocation of the company’s result

2020-05-20
Qlife Holding AB, Interim Report January – March 2020

FINANCIAL SUMMARY FIRST QUARTER 2020

2020-05-12
Qlife has entered a first strategically important sales agreement for their COVID-19 test

The parties have agreed a testing plan for all players, judges and club staff for Covid-19 in the professional leagues (3F SuperLiga and NordicBet Liga).